A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session607810e2474c03a1b827e9d49148844b823c1913): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global PEG-modified Drugs Market Research Report 2024

img

Global PEG-modified Drugs Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global PEG-modified Drugs Market Research Report 2024

Polyethylene glycol modified drug refers to a method of drug modification that combines polyethylene glycol molecules with drug molecules to improve the properties, pharmacokinetics and pharmacodynamic properties of drugs. This modification is often used to improve drug solubility, stability, bioavailability, and drug distribution.
According to MRAResearch’s new survey, global PEG-modified Drugs market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole PEG-modified Drugs market research.
Key companies engaged in the PEG-modified Drugs industry include Merck Sharp & Dohme, Baxalta Inc., Amgen Inc., Roche, UCB S.A., Enzon, Horizon Pharma Plc, Biogen Inc. and Qilu Pharmaceutical Co., Ltd., etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of PEG-modified Drugs were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole PEG-modified Drugs market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global PEG-modified Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Merck Sharp & Dohme
Baxalta Inc.
Amgen Inc.
Roche
UCB S.A.
Enzon
Horizon Pharma Plc
Biogen Inc.
Qilu Pharmaceutical Co., Ltd.
CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Changchun Genescience Pharmaceutical Co., Ltd.
Xiamen Amoytop Biotech Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Hansoh Pharmaceuticak Group Co.,Ltd.
SunBio
Xiamen Sano banger Biotechnology Co., Ltd
Segment by Type
PEG Amidation
PEGylation
PEG Peptidation
PEG Etherification
Other Combinations

Segment by Application


Cancer Treatment
Diabetes Treatment
Immunomodulatory
Anti-inflammatory Treatment
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The PEG-modified Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PEG-modified Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 PEG Amidation
1.2.3 PEGylation
1.2.4 PEG Peptidation
1.2.5 PEG Etherification
1.2.6 Other Combinations
1.3 Market by Application
1.3.1 Global PEG-modified Drugs Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cancer Treatment
1.3.3 Diabetes Treatment
1.3.4 Immunomodulatory
1.3.5 Anti-inflammatory Treatment
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PEG-modified Drugs Market Perspective (2018-2033)
2.2 PEG-modified Drugs Growth Trends by Region
2.2.1 Global PEG-modified Drugs Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 PEG-modified Drugs Historic Market Size by Region (2018-2023)
2.2.3 PEG-modified Drugs Forecasted Market Size by Region (2024-2033)
2.3 PEG-modified Drugs Market Dynamics
2.3.1 PEG-modified Drugs Industry Trends
2.3.2 PEG-modified Drugs Market Drivers
2.3.3 PEG-modified Drugs Market Challenges
2.3.4 PEG-modified Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PEG-modified Drugs Players by Revenue
3.1.1 Global Top PEG-modified Drugs Players by Revenue (2018-2023)
3.1.2 Global PEG-modified Drugs Revenue Market Share by Players (2018-2023)
3.2 Global PEG-modified Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PEG-modified Drugs Revenue
3.4 Global PEG-modified Drugs Market Concentration Ratio
3.4.1 Global PEG-modified Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PEG-modified Drugs Revenue in 2022
3.5 PEG-modified Drugs Key Players Head office and Area Served
3.6 Key Players PEG-modified Drugs Product Solution and Service
3.7 Date of Enter into PEG-modified Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PEG-modified Drugs Breakdown Data by Type
4.1 Global PEG-modified Drugs Historic Market Size by Type (2018-2023)
4.2 Global PEG-modified Drugs Forecasted Market Size by Type (2024-2033)
5 PEG-modified Drugs Breakdown Data by Application
5.1 Global PEG-modified Drugs Historic Market Size by Application (2018-2023)
5.2 Global PEG-modified Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America PEG-modified Drugs Market Size (2018-2033)
6.2 North America PEG-modified Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America PEG-modified Drugs Market Size by Country (2018-2023)
6.4 North America PEG-modified Drugs Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PEG-modified Drugs Market Size (2018-2033)
7.2 Europe PEG-modified Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe PEG-modified Drugs Market Size by Country (2018-2023)
7.4 Europe PEG-modified Drugs Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PEG-modified Drugs Market Size (2018-2033)
8.2 Asia-Pacific PEG-modified Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific PEG-modified Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific PEG-modified Drugs Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PEG-modified Drugs Market Size (2018-2033)
9.2 Latin America PEG-modified Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America PEG-modified Drugs Market Size by Country (2018-2023)
9.4 Latin America PEG-modified Drugs Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PEG-modified Drugs Market Size (2018-2033)
10.2 Middle East & Africa PEG-modified Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa PEG-modified Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa PEG-modified Drugs Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck Sharp & Dohme
11.1.1 Merck Sharp & Dohme Company Detail
11.1.2 Merck Sharp & Dohme Business Overview
11.1.3 Merck Sharp & Dohme PEG-modified Drugs Introduction
11.1.4 Merck Sharp & Dohme Revenue in PEG-modified Drugs Business (2018-2023)
11.1.5 Merck Sharp & Dohme Recent Development
11.2 Baxalta Inc.
11.2.1 Baxalta Inc. Company Detail
11.2.2 Baxalta Inc. Business Overview
11.2.3 Baxalta Inc. PEG-modified Drugs Introduction
11.2.4 Baxalta Inc. Revenue in PEG-modified Drugs Business (2018-2023)
11.2.5 Baxalta Inc. Recent Development
11.3 Amgen Inc.
11.3.1 Amgen Inc. Company Detail
11.3.2 Amgen Inc. Business Overview
11.3.3 Amgen Inc. PEG-modified Drugs Introduction
11.3.4 Amgen Inc. Revenue in PEG-modified Drugs Business (2018-2023)
11.3.5 Amgen Inc. Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche PEG-modified Drugs Introduction
11.4.4 Roche Revenue in PEG-modified Drugs Business (2018-2023)
11.4.5 Roche Recent Development
11.5 UCB S.A.
11.5.1 UCB S.A. Company Detail
11.5.2 UCB S.A. Business Overview
11.5.3 UCB S.A. PEG-modified Drugs Introduction
11.5.4 UCB S.A. Revenue in PEG-modified Drugs Business (2018-2023)
11.5.5 UCB S.A. Recent Development
11.6 Enzon
11.6.1 Enzon Company Detail
11.6.2 Enzon Business Overview
11.6.3 Enzon PEG-modified Drugs Introduction
11.6.4 Enzon Revenue in PEG-modified Drugs Business (2018-2023)
11.6.5 Enzon Recent Development
11.7 Horizon Pharma Plc
11.7.1 Horizon Pharma Plc Company Detail
11.7.2 Horizon Pharma Plc Business Overview
11.7.3 Horizon Pharma Plc PEG-modified Drugs Introduction
11.7.4 Horizon Pharma Plc Revenue in PEG-modified Drugs Business (2018-2023)
11.7.5 Horizon Pharma Plc Recent Development
11.8 Biogen Inc.
11.8.1 Biogen Inc. Company Detail
11.8.2 Biogen Inc. Business Overview
11.8.3 Biogen Inc. PEG-modified Drugs Introduction
11.8.4 Biogen Inc. Revenue in PEG-modified Drugs Business (2018-2023)
11.8.5 Biogen Inc. Recent Development
11.9 Qilu Pharmaceutical Co., Ltd.
11.9.1 Qilu Pharmaceutical Co., Ltd. Company Detail
11.9.2 Qilu Pharmaceutical Co., Ltd. Business Overview
11.9.3 Qilu Pharmaceutical Co., Ltd. PEG-modified Drugs Introduction
11.9.4 Qilu Pharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023)
11.9.5 Qilu Pharmaceutical Co., Ltd. Recent Development
11.10 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
11.10.1 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Company Detail
11.10.2 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Business Overview
11.10.3 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. PEG-modified Drugs Introduction
11.10.4 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023)
11.10.5 CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Recent Development
11.11 Changchun Genescience Pharmaceutical Co., Ltd.
11.11.1 Changchun Genescience Pharmaceutical Co., Ltd. Company Detail
11.11.2 Changchun Genescience Pharmaceutical Co., Ltd. Business Overview
11.11.3 Changchun Genescience Pharmaceutical Co., Ltd. PEG-modified Drugs Introduction
11.11.4 Changchun Genescience Pharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023)
11.11.5 Changchun Genescience Pharmaceutical Co., Ltd. Recent Development
11.12 Xiamen Amoytop Biotech Co., Ltd.
11.12.1 Xiamen Amoytop Biotech Co., Ltd. Company Detail
11.12.2 Xiamen Amoytop Biotech Co., Ltd. Business Overview
11.12.3 Xiamen Amoytop Biotech Co., Ltd. PEG-modified Drugs Introduction
11.12.4 Xiamen Amoytop Biotech Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023)
11.12.5 Xiamen Amoytop Biotech Co., Ltd. Recent Development
11.13 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
11.13.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Detail
11.13.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Business Overview
11.13.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. PEG-modified Drugs Introduction
11.13.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023)
11.13.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Development
11.14 Hansoh Pharmaceuticak Group Co.,Ltd.
11.14.1 Hansoh Pharmaceuticak Group Co.,Ltd. Company Detail
11.14.2 Hansoh Pharmaceuticak Group Co.,Ltd. Business Overview
11.14.3 Hansoh Pharmaceuticak Group Co.,Ltd. PEG-modified Drugs Introduction
11.14.4 Hansoh Pharmaceuticak Group Co.,Ltd. Revenue in PEG-modified Drugs Business (2018-2023)
11.14.5 Hansoh Pharmaceuticak Group Co.,Ltd. Recent Development
11.15 SunBio
11.15.1 SunBio Company Detail
11.15.2 SunBio Business Overview
11.15.3 SunBio PEG-modified Drugs Introduction
11.15.4 SunBio Revenue in PEG-modified Drugs Business (2018-2023)
11.15.5 SunBio Recent Development
11.16 Xiamen Sano banger Biotechnology Co., Ltd
11.16.1 Xiamen Sano banger Biotechnology Co., Ltd Company Detail
11.16.2 Xiamen Sano banger Biotechnology Co., Ltd Business Overview
11.16.3 Xiamen Sano banger Biotechnology Co., Ltd PEG-modified Drugs Introduction
11.16.4 Xiamen Sano banger Biotechnology Co., Ltd Revenue in PEG-modified Drugs Business (2018-2023)
11.16.5 Xiamen Sano banger Biotechnology Co., Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global PEG-modified Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of PEG Amidation
Table 3. Key Players of PEGylation
Table 4. Key Players of PEG Peptidation
Table 5. Key Players of PEG Etherification
Table 6. Key Players of Other Combinations
Table 7. Global PEG-modified Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global PEG-modified Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global PEG-modified Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global PEG-modified Drugs Market Share by Region (2018-2023)
Table 11. Global PEG-modified Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global PEG-modified Drugs Market Share by Region (2024-2033)
Table 13. PEG-modified Drugs Market Trends
Table 14. PEG-modified Drugs Market Drivers
Table 15. PEG-modified Drugs Market Challenges
Table 16. PEG-modified Drugs Market Restraints
Table 17. Global PEG-modified Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global PEG-modified Drugs Market Share by Players (2018-2023)
Table 19. Global Top PEG-modified Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEG-modified Drugs as of 2022)
Table 20. Ranking of Global Top PEG-modified Drugs Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by PEG-modified Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players PEG-modified Drugs Product Solution and Service
Table 24. Date of Enter into PEG-modified Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global PEG-modified Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global PEG-modified Drugs Revenue Market Share by Type (2018-2023)
Table 28. Global PEG-modified Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global PEG-modified Drugs Revenue Market Share by Type (2024-2033)
Table 30. Global PEG-modified Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global PEG-modified Drugs Revenue Market Share by Application (2018-2023)
Table 32. Global PEG-modified Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global PEG-modified Drugs Revenue Market Share by Application (2024-2033)
Table 34. North America PEG-modified Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America PEG-modified Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America PEG-modified Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe PEG-modified Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe PEG-modified Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe PEG-modified Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific PEG-modified Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific PEG-modified Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific PEG-modified Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America PEG-modified Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America PEG-modified Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America PEG-modified Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa PEG-modified Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa PEG-modified Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa PEG-modified Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 49. Merck Sharp & Dohme Company Detail
Table 50. Merck Sharp & Dohme Business Overview
Table 51. Merck Sharp & Dohme PEG-modified Drugs Product
Table 52. Merck Sharp & Dohme Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 53. Merck Sharp & Dohme Recent Development
Table 54. Baxalta Inc. Company Detail
Table 55. Baxalta Inc. Business Overview
Table 56. Baxalta Inc. PEG-modified Drugs Product
Table 57. Baxalta Inc. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 58. Baxalta Inc. Recent Development
Table 59. Amgen Inc. Company Detail
Table 60. Amgen Inc. Business Overview
Table 61. Amgen Inc. PEG-modified Drugs Product
Table 62. Amgen Inc. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 63. Amgen Inc. Recent Development
Table 64. Roche Company Detail
Table 65. Roche Business Overview
Table 66. Roche PEG-modified Drugs Product
Table 67. Roche Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 68. Roche Recent Development
Table 69. UCB S.A. Company Detail
Table 70. UCB S.A. Business Overview
Table 71. UCB S.A. PEG-modified Drugs Product
Table 72. UCB S.A. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 73. UCB S.A. Recent Development
Table 74. Enzon Company Detail
Table 75. Enzon Business Overview
Table 76. Enzon PEG-modified Drugs Product
Table 77. Enzon Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 78. Enzon Recent Development
Table 79. Horizon Pharma Plc Company Detail
Table 80. Horizon Pharma Plc Business Overview
Table 81. Horizon Pharma Plc PEG-modified Drugs Product
Table 82. Horizon Pharma Plc Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 83. Horizon Pharma Plc Recent Development
Table 84. Biogen Inc. Company Detail
Table 85. Biogen Inc. Business Overview
Table 86. Biogen Inc. PEG-modified Drugs Product
Table 87. Biogen Inc. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 88. Biogen Inc. Recent Development
Table 89. Qilu Pharmaceutical Co., Ltd. Company Detail
Table 90. Qilu Pharmaceutical Co., Ltd. Business Overview
Table 91. Qilu Pharmaceutical Co., Ltd. PEG-modified Drugs Product
Table 92. Qilu Pharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 93. Qilu Pharmaceutical Co., Ltd. Recent Development
Table 94. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Company Detail
Table 95. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Business Overview
Table 96. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. PEG-modified Drugs Product
Table 97. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 98. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Recent Development
Table 99. Changchun Genescience Pharmaceutical Co., Ltd. Company Detail
Table 100. Changchun Genescience Pharmaceutical Co., Ltd. Business Overview
Table 101. Changchun Genescience Pharmaceutical Co., Ltd. PEG-modified Drugs Product
Table 102. Changchun Genescience Pharmaceutical Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 103. Changchun Genescience Pharmaceutical Co., Ltd. Recent Development
Table 104. Xiamen Amoytop Biotech Co., Ltd. Company Detail
Table 105. Xiamen Amoytop Biotech Co., Ltd. Business Overview
Table 106. Xiamen Amoytop Biotech Co., Ltd. PEG-modified Drugs Product
Table 107. Xiamen Amoytop Biotech Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 108. Xiamen Amoytop Biotech Co., Ltd. Recent Development
Table 109. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Company Detail
Table 110. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Business Overview
Table 111. Jiangsu Hengrui Pharmaceuticals Co., Ltd. PEG-modified Drugs Product
Table 112. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 113. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Development
Table 114. Hansoh Pharmaceuticak Group Co.,Ltd. Company Detail
Table 115. Hansoh Pharmaceuticak Group Co.,Ltd. Business Overview
Table 116. Hansoh Pharmaceuticak Group Co.,Ltd. PEG-modified Drugs Product
Table 117. Hansoh Pharmaceuticak Group Co.,Ltd. Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 118. Hansoh Pharmaceuticak Group Co.,Ltd. Recent Development
Table 119. SunBio Company Detail
Table 120. SunBio Business Overview
Table 121. SunBio PEG-modified Drugs Product
Table 122. SunBio Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 123. SunBio Recent Development
Table 124. Xiamen Sano banger Biotechnology Co., Ltd Company Detail
Table 125. Xiamen Sano banger Biotechnology Co., Ltd Business Overview
Table 126. Xiamen Sano banger Biotechnology Co., Ltd PEG-modified Drugs Product
Table 127. Xiamen Sano banger Biotechnology Co., Ltd Revenue in PEG-modified Drugs Business (2018-2023) & (US$ Million)
Table 128. Xiamen Sano banger Biotechnology Co., Ltd Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PEG-modified Drugs Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global PEG-modified Drugs Market Share by Type: 2022 VS 2033
Figure 3. PEG Amidation Features
Figure 4. PEGylation Features
Figure 5. PEG Peptidation Features
Figure 6. PEG Etherification Features
Figure 7. Other Combinations Features
Figure 8. Global PEG-modified Drugs Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global PEG-modified Drugs Market Share by Application: 2022 VS 2033
Figure 10. Cancer Treatment Case Studies
Figure 11. Diabetes Treatment Case Studies
Figure 12. Immunomodulatory Case Studies
Figure 13. Anti-inflammatory Treatment Case Studies
Figure 14. Others Case Studies
Figure 15. PEG-modified Drugs Report Years Considered
Figure 16. Global PEG-modified Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global PEG-modified Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global PEG-modified Drugs Market Share by Region: 2022 VS 2033
Figure 19. Global PEG-modified Drugs Market Share by Players in 2022
Figure 20. Global Top PEG-modified Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PEG-modified Drugs as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by PEG-modified Drugs Revenue in 2022
Figure 22. North America PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America PEG-modified Drugs Market Share by Country (2018-2033)
Figure 24. United States PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe PEG-modified Drugs Market Share by Country (2018-2033)
Figure 28. Germany PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific PEG-modified Drugs Market Share by Region (2018-2033)
Figure 36. China PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America PEG-modified Drugs Market Share by Country (2018-2033)
Figure 44. Mexico PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa PEG-modified Drugs Market Share by Country (2018-2033)
Figure 48. Turkey PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia PEG-modified Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Merck Sharp & Dohme Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 51. Baxalta Inc. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 52. Amgen Inc. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 53. Roche Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 54. UCB S.A. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 55. Enzon Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 56. Horizon Pharma Plc Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 57. Biogen Inc. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 58. Qilu Pharmaceutical Co., Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 59. CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 60. Changchun Genescience Pharmaceutical Co., Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 61. Xiamen Amoytop Biotech Co., Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 62. Jiangsu Hengrui Pharmaceuticals Co., Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 63. Hansoh Pharmaceuticak Group Co.,Ltd. Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 64. SunBio Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 65. Xiamen Sano banger Biotechnology Co., Ltd Revenue Growth Rate in PEG-modified Drugs Business (2018-2023)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries